Cargando…
Understanding COVID-19: From Origin to Potential Therapeutics
Currently, a global pandemic era of public health concerns is going on with the Coronavirus Disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The first case of COVID-19 was reported from Wuhan’s Huanan seafood market in China late December 2019...
Autores principales: | Moazzam, Muhammad, Sajid, Muhammad Imran, Shahid, Hamza, Butt, Jahanzaib, Bashir, Irfan, Jamshaid, Muhammad, Shirazi, Amir Nasrolahi, Tiwari, Rakesh Kumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460442/ https://www.ncbi.nlm.nih.gov/pubmed/32823901 http://dx.doi.org/10.3390/ijerph17165904 |
Ejemplares similares
-
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
por: Sajid, Muhammad Imran, et al.
Publicado: (2020) -
Synthesis and Antiproliferative Activities of Conjugates of Paclitaxel and Camptothecin with a Cyclic Cell-Penetrating Peptide
por: El-Sayed, Naglaa Salem, et al.
Publicado: (2019) -
Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools
por: Nasrolahi Shirazi, Amir, et al.
Publicado: (2021) -
Cyclic Peptide-Gadolinium Nanoparticles for Enhanced Intracellular Delivery
por: Shirazi, Amir Nasrolahi, et al.
Publicado: (2020) -
Illicit sale of controlled drugs at community pharmacy/medical stores of Punjab, Pakistan: A road to demolition of public health
por: Bashir, Irfan, et al.
Publicado: (2021)